Introduction
Results and discussion
Ag(I) ions predominately retard Aβ fibril-end elongation

Interaction between Aβ monomers and Ag(I) ions

Silver ions induce a more compact structure in Aβ

Chemical exchange between Aβ–Ag(I) complex and free peptide
Insights into metal-ion binding mechanisms and effects on aggregation comparing Ag(I) and Zn(II)

Concluding remarks
Experimental procedures
Sample preparation
pFTAA and ThT fibrillization kinetics using fluorescence spectroscopy
Global fit analysis
Seeding experiments
Solid-state AFM imaging and circular dichroism spectroscopy
NMR spectroscopy
The spectra were referenced to the 1H signal of trimethylsilylpropanoic acid. The Aβ40 amide cross-peak assignment in the HSQC spectra was performed by comparison with previously published work (
in which Dfree and DB are the diffusion coefficient of the free and the bound state, respectively, with the respective populations. Additionally, a global fit analysis of the diffusion data from Ag(I) and Zn(II) (
Dissociation constant determination for Ag(I) binding
- Tiiman A.
- Luo J.
- Wallin C.
- Olsson L.
- Lindgren J.
- Jarvet J.
- Per R.
- Sholts S.B.
- Rahimipour S.
- Abrahams J.P.
- Karlström A.E.
- Gräslund A.
- Wärmländer S.K.
where I∞ is the intensity upon saturation, I0 is the initial intensity without Ag(I) ions, and KDapp is the apparent dissociation constant. From NMR relaxation dispersion experiments, an apparent KDapp value was determined using the bound population pB.
Data availability
Author contributions
Acknowledgments
Supplementary Material
References
- Metal binding affinity and selectivity in metalloproteins: insights from computational studies.Annu. Rev. Biophys. 2008; 37 (18573074): 97-116
- Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.Biochem. Biophys. Res. Commun. 1984; 120 (6375662): 885-890
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide.Nat. Rev. Mol. Cell Biol. 2007; 8 (17245412): 101-112
- Dynamics and control of peptide self-assembly and aggregation.Adv. Exp. Med. Biol. 2019; 1174 (31713195): 1-33
- From macroscopic measurements to microscopic mechanisms of protein aggregation.J. Mol. Biol. 2012; 421 (22406275): 160-171
- Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.Proc. Natl. Acad. Sci. U.S.A. 2013; 110 (23703910): 9758-9763
- The amyloid state and its association with protein misfolding diseases.Nat. Rev. Mol. Cell Biol. 2014; 15 (24854788): 384-396
- Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide.Dalt. Trans. 2009; 7 (19322475): 1080-1094
- Effects of Cu(II) on the aggregation of amyloid-β.J. Biol. Inorg. Chem. 2019; 24 (31602542): 1197-1215
- Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules.Chembiochem. 2013; 14 (23983094): 1692-1704
- Effect of metals on kinetic pathways of amyloid-β aggregation.Biomolecules. 2014; 4 (24970207): 101-116
- The amyloid-β peptide in amyloid formation processes: interactions with blood proteins and naturally occurring metal ions.Isr. J. Chem. 2017; 57: 674-685
- Iron(II) binding to amyloid-β, the Alzheimer's peptide.Inorg. Chem. 2011; 50 (21800824): 9024-9030
- Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.Proc. Natl. Acad. Sci. U.S.A. 2015; 112 (25825723): 5407-5412
- Metallostasis in Alzheimer's disease.Free Radic. Biol. Med. 2013; 62 (23142767): 76-89
- Metals in Alzheimer's and Parkinson's diseases.Curr. Opin. Chem. Biol. 2008; 12 (18342639): 222-228
- Biometals and their therapeutic implications in Alzheimer's disease.Neurotherapeutics. 2015; 12 (25354461): 109-120
- Copper, iron and zinc in Alzheimer's disease senile plaques.J. Neurol. Sci. 1998; 158 (9667777): 47-52
- Characterization of Mn(II) ion binding to the amyloid-β peptide in Alzheimer's disease.J. Trace Elem. Med. Biol. 2016; 38 (27085215): 183-193
- Copper and zinc binding to amyloid-β: coordination, dynamics, aggregation, reactivity and metal-ion transfer.ChemBioChem. 2009; 10 (19877000): 2837-2845
- Identifying the minimal copper- and zinc-binding site sequence in amyloid-β peptides.J. Biol. Chem. 2008; 283 (18234670): 10784-10792
- Mercury and Alzheimer's disease: Hg(II) ions display specific binding to the amyloid-β peptide and hinder its fibrillization.Biomolecules. 2019; 10 (31892131): E44
- Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation.Sci. Rep. 2017; 7 (29089568): 14423
- Monomeric Aβ1–40 and Aβ1–42 peptides in solution adopt very similar Ramachandran map distributions that closely resemble random coil.Biochemistry. 2016; 55 (26780756): 762-775
- The Alzheimer β-peptide shows temperature-dependent transitions between left-handed 31-helix, β-strand and random coil secondary structures.FEBS J. 2005; 272 (16045764): 3938-3949
- The amyloid state of proteins in human diseases.Cell. 2012; 148 (22424229): 1188-1203
- X-ray fibre diffraction studies of amyloid fibrils.Methods Mol. Biol. 2012; 849 (22528087): 121-135
- High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid β-peptide.FEBS J. 2007; 274 (17222176): 46-59
- Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.Acc. Chem. Res. 2014; 47 (24871565): 2252-2259
- Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation.Biophys. J. 2011; 101 (21889458): 1202-1211
- Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide.Inorg. Chem. 2013; 52 (23607830): 12193-12206
- Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.J. Neurochem. 2009; 110 (19619132): 1784-1795
- Rapid formation of a preoligomeric peptide–metal–peptide complex following copper(II) binding to amyloid β peptides.Angew. Chem. Int. Ed. Engl. 2011; 50 (21370331): 2532-2535
- The pathogenic A2V mutant exhibits distinct aggregation kinetics, metal site structure, and metal exchange of the Cu2+–Aβ complex.Chemistry. 2017; 23 (28815875): 13591-13595
- Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.Science. 1981; 211 (6162199): 1437-1438
- Silver staining of proteins in polyacrylamide gels.Nat. Protoc. 2006; 1 (17487168): 1852-1858
- Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine.Chem. Rev. 2013; 113 (23488929): 4708-4754
- XAS investigation of silver(I) coordination in copper(I) biological binding sites.Inorg. Chem. 2015; 54 (26632864): 11688-11696
- The tachykinin peptide neurokinin B binds copper(I) and silver(I) and undergoes quasi-reversible electrochemistry: towards a new function for the peptide in the brain.Neurochem. Int. 2014; 70 (24650723): 1-9
- NMR investigations of metal interactions with unstructured soluble protein domains.Coord. Chem. Rev. 2014; 269: 1-12
- Specific binding modes of Cu(I) and Ag(I) with neurotoxic domain of the human prion protein.J. Inorg. Biochem. 2016; 155 (26606290): 26-35
- Structural analysis of copper(I) interaction with amyloid β peptide.J. Inorg. Biochem. 2019; 195 (30884319): 31-38
- Quantitative analysis of intrinsic and extrinsic factors in the aggregation mechanism of Alzheimer-associated Aβ-peptide.Sci. Rep. 2016; 6 (26758487): 18728
- On the role of sidechain size and charge in the aggregation of A β 42 with familial mutations.Proc. Natl. Acad. Sci. U.S.A. 2018; 115 (29895690): E5849-E5858
- Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide.Nat. Chem. 2018; 10 (29581486): 523-531
- Ionic strength modulation of the free energy landscape of Aβ40 peptide fibril formation.J. Am. Chem. Soc. 2016; 138 (27171340): 6893-6902
- Modulation of electrostatic interactions to reveal a reaction network unifying the aggregation behaviour of the Aβ42 peptide and its variants.Chem. Sci. 2017; 8 (28979758): 4352-4362
- Molecular mechanism of thioflavin-T binding to amyloid fibrils.Biochim. Biophys. Acta. 2010; 1804 (20399286): 1405-1412
- Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates.Org. Biomol. Chem. 2011; 9 (22051883): 8356-8370
- Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides.Proc. Natl. Acad. Sci. U.S.A. 2014; 111 (24938782): 9384-9389
- Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation.Nat. Commun. 2016; 7 (27009901): 10948
- A label-free oligonucleotide based thioflavin-t fluorescent switch for Ag+ detection with low background emission.J. Fluoresc. 2012; 22 (22234459): 925-929
- Water-soluble hybrid nanoclusters with extra bright and photostable emissions: a new tool for biological imaging.Biophys. J. 2005; 89 (15833997): 572-580
- An analytical solution to the kinetics of breakable filament assembly.Science. 2009; 326 (20007899): 1533-1537
- Nucleated polymerization with secondary pathways: I. Time evolution of the principal moments.J. Chem. Phys. 2011; 135 (065105) (21842954)
- Positioning of the Alzheimer Aβ(1–40) peptide in SDS micelles using NMR and paramagnetic probes.J. Biomol. NMR. 2007; 39 (17657567): 63-72
- Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient.J. Chem. Phys. 1965; 42: 288-292
- Determination of the effective hydrodynamic radii of small molecules by viscometry.J. Gen. Physiol. 1961; 44 (13748878): 1189-1199
- A modified Stokes–Einstein equation for Aβ aggregation.BMC Bioinformatics. 2011; 12: S13
- Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules.Methods Enzymol. 2001; 339 (11462813): 204-238
- Effects of diffusion on free precession in nuclear magnetic resonance experiments.Phys. Rev. 1954; 94: 630-638
- Modified spin-echo method for measuring nuclear relaxation times.Rev. Sci. Instrum. 1958; 29: 688-691
- Slow dynamics in folded and unfolded states of an SH3 domain.J. Am. Chem. Soc. 2001; 123 (11707108): 11341-11352
- Transient small molecule interactions kinetically modulate amyloid β peptide self-assembly.FEBS Lett. 2012; 586 (Correction) (23058290): 3991-3995FEBS Lett. 2013; 587 (Correction) (23058290): 1452
- Specific binding of Cu(II) ions to amyloid-β peptides bound to aggregation-inhibiting molecules or SDS micelles creates complexes that generate radical oxygen species.J. Alzheimers Dis. 2016; 54 (27567855): 971-982
- Kinetic analysis of β-amyloid fibril elongation.Anal. Biochem. 2004; 328 (15081909): 67-75
- Thermodynamics of Aβ(1–40) amyloid fibril elongation.Biochemistry. 2005; 44 (16171385): 12709-12718
- Chemical kinetics for drug discovery to combat protein aggregation diseases.Trends Pharmacol. Sci. 2014; 35 (24560688): 127-135
- A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers.Nat. Struct. Mol. Biol. 2015; 22 (25686087): 207-213
- Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state.Nat. Commun. 2017; 8 (29234026): 2081
- Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation.R. Soc. Open Sci. 2017; 4 (28280572): 160696
- Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process.ACS Chem. Neurosci. 2010; 1 (22778803): 13-18
- Molecular mechanisms of protein aggregation from global fitting of kinetic models.Nat. Protoc. 2016; 11 (26741409): 252-272
- Using chemical shift perturbation to characterise ligand binding.Prog. Nucl. Magn. Reson. Spectrosc. 2013; 73 (23962882): 1-16
- N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity.Protein Sci. 2010; 19 (20886513): 2319-2329
- Thermal offset viscosities of liquid H2O, D2O, and T2O.J. Phys. Chem. B. 1999; 103: 1991-1994
Article info
Publication history
Footnotes
This work was supported by Alzheimer Foundation Grant AF-642731 (to A. G.), Swedish Research Council Grant 2014-05867 (to A. G.), Latvian Science Council lzp-2018/1-0275 (to H. B.), and grants from the Magnus Bergvall Foundation (to A. A. and H. B.), the Åhlen Foundation (to A. A.), the Loo and Hans Osterman Foundation (to A. A.), and the Geriatric Diseases Foundation at Karolinska Institutet (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.
This article contains supporting text, Tables S1–S7, and Figs. S1–S15.
Identification
Copyright
User license
Creative Commons Attribution (CC BY 4.0) |
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy